Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease.

Chronic kidney disease affects ~10% of people worldwide and there are no disease modifying therapeutics that address the underlying cause of any form of kidney disease. Genome wide association studies have identified the G1 and G2 variants in the apolipoprotein L1 (APOL1) gene as major contributors to a subtype of proteinuric kidney disease now referred to as APOL1-mediated kidney disease (AMKD). We hypothesized that inhibition of APOL1 could have therapeutic potential for this genetically-defined form of kidney disease.

Hemodynamic cortical ripples through cyclicity analysis.

A fine-grained understanding of dynamics in cortical networks is crucial to unpacking brain function. Resting-state functional magnetic resonance imaging (fMRI) gives rise to time series recordings of the activity of different brain regions, which are aperiodic and lack a base frequency. Cyclicity analysis, a novel technique robust under time reparametrizations, is effective in recovering the temporal ordering of such time series, collectively considered components of a multidimensional trajectory.

Activity measurements and calibrations for Ac in radioactive equilibrium with its progeny.

The massic activity of Ac in 0.1 mol/L HCl was measured by multiple primary methods over four consistent measurement campaigns. Results from the triple-to-double coincidence ratio (TDCR) method of liquid scintillation (LS) counting were in accord with other LS-based primary methods.

The Influence of X Chromosome Parent-of-Origin on Glycemia in Individuals with Turner Syndrome.

Introduction: The cause of increased diabetes mellitus (DM) risk in individuals with Turner syndrome (TS) is poorly understood. Parent-of-origin effects related to whether the maternal or paternal X chromosome (Xchr) remains intact have been found for several TS phenotypes, including hypercholesterolemia. Therefore, Xchr parent-of-origin may impact DM risk in TS.